Talis Biomedical Corporation Common Stock
Exchange: NASDAQ
Symbol: TLIS
SEC CIK: 0001584751
Phone: 650-433-3000
230 CONSTITUTION DRIVE
MENLO PARK CA 94025
CEO:
|
Price when page updated: 7.5199 Date: 2023-12-01
Company Website:
https://talis.bio
|
_Description: Talis is dedicated to transforming diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, low cost and rapid molecular testing for infectious diseases at the point-of-care, beginning with COVID-19. The company is developing Talis One, a compact, sample-to-answer, cloud-enabled, molecular diagnostic platform. Talis is headquartered in Menlo Park, California.
IPO YEAR:
2021
|
Sector:
Health Care
|
Industry:
Biotechnology: Electromedical & Electrotherapeutic Apparatus
|
ADRTSO:
|
MarketCap:
13694700.00
|
Beta:
|
52 Week High:
33.9
|
52 Week Low:
3.64
|
52 Week Change:
-0.8510791366906475
|
Short Interest:
|
Short Date:
|
Shares Outstanding:
26288616
|
Dividend Rate:
0
|
Dividend Yield:
0.00%
|
ExDividend Date:
|
Latest EPS:
|
Latest EPS Date:
3 Nov 2022
|
Float:
0
|
return on Equity:
-
|
Consensus EPS:
|
Number Of Estimates:
|
EPS Surprise Dollar:
|
Eps Surprise Percent:
|
EBITDA:
-$235.52
|
ttmEPS:
0
|
Revenue:
$1.010B
|
Gross Profit:
|
Cash:
|
Debt:
|
Institution Percent:
30.10%
|
Revenue Percent:
|
Revenue Per Employee:
|
Insider Percent:
41.70%
|
Return on Assets:
-
|
Return on Capital:
|
Profit Margin:
-
|
Price to Sales:
0.54
|
Price To Book:
0.71
|
Short Ratio:
1.23
|
PE Ratio:
0
|
Employees:
135
|
1Y Guesstimate
N/A:N/A:N/A
|
|
|
|
|
|
|
|
|
__The following are links to various summary and news pages for
__Talis Biomedical Corporation Common Stock [ TLIS ].
__Note: Some Links might not have information for the company.
|
|
